Problem Areas in Diabetes Scale (PAID)
Also known as: PAID
The Problem Areas in Diabetes Scale (PAID) is a 20-item self-report measure that assesses emotional and behavioral problems related to diabetes self-management, including worries about complications, regimen burden, social and family challenges, and emotional distress. Originally developed by Polonsky and colleagues in 1995, the PAID has been extensively validated and remains one of the most widely used diabetes-specific emotional assessment tools in research and clinical practice, particularly for identifying psychosocial barriers to optimal diabetes control.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The PAID is recommended for screening and monitoring all patients with type 1 or type 2 diabetes in primary care, endocrinology, specialty diabetes clinics, and integrated behavioral health settings. Specific indications include: (1) baseline screening at diabetes diagnosis or clinic enrollment, (2) periodic reassessment (annually) in stable patients or more frequently (every 3–6 months) in newly diagnosed or poorly controlled patients, (3) identification of patients who would benefit from diabetes education, behavioral counseling, or psychosocial support (PAID ≥40), (4) outcome measurement in diabetes education programs and psychosocial interventions, (5) research examining relationships between emotional distress and glycemic control or adherence, and (6) shared decision-making with patients about treatment goals and psychosocial support needs.
Strengths & limitations
- Diabetes-specific emotional assessment: PAID directly measures emotion and behavioral problems unique to diabetes self-management, capturing concerns generic instruments miss.
- Predictive of clinical outcomes: elevated PAID is associated with poor glycemic control, reduced adherence, and worse quality of life; PAID is both a marker of distress and a prognostic indicator.
- Responsive to intervention: PAID demonstrates meaningful change following diabetes education, counseling, cognitive-behavioral therapy, or psychosocial support; sensitive outcome for research.
- Brief and practical: 20 items, 5–8 minute administration, easy scoring and interpretation support wide clinical use.
- Extensively validated: PAID has been translated into >20 languages and validated in diverse populations (type 1, type 2, elderly, pregnant women with gestational diabetes, diverse ethnic groups).
- Does not distinguish generalized depression from diabetes-specific distress: PAID correlates with depressive symptoms (PHQ-9); elevated PAID may reflect comorbid depression rather than solely diabetes-related emotional burden.
- No validated subscales: while some domain structure has been proposed post-hoc, the original PAID does not have formally validated subscales; total score is the primary outcome.
- Modest predictive power for behavior change: PAID identifies distress but does not strongly predict whether individual patients will improve with intervention; high PAID requires concurrent assessment of barriers (knowledge, motivation, resources).
- Cross-cultural validity concerns: most validation data come from high-income, English-speaking populations; cultural differences in emotional expression and disease perception may affect interpretation.
- Threshold variability: recommended cutoff of PAID ≥40 for referral is somewhat arbitrary; clinical judgment about intervention need should incorporate other factors (HbA1c, adherence, psychosocial resources).
Frequently asked
What is the difference between PAID and DDS?
PAID (20 items, 0–80) and DDS (17 items, 1–6 scale) both measure diabetes-specific emotional distress, but DDS was developed more recently (2005) and has stronger theoretical structure with four validated subscales. DDS may be more specific for 'diabetes distress' (regimen, physician, emotional, interpersonal domains), while PAID is broader and includes problem areas (complications worry, family, social). Both are valid; choice depends on whether single-score (PAID) or multidimensional (DDS) detail is preferred.
What PAID score indicates need for mental health referral?
PAID ≥60 (on 0–100 scale) indicates significant emotional burden and warrants structured psychosocial assessment. Before assuming need for psychiatry or antidepressants, screen with PHQ-9 (depression) or GAD-7 (anxiety) to distinguish diabetes-specific distress from diagnosable mental illness. A patient with PAID 65 but PHQ-9 5 (no depression) benefits from diabetes-specific psychosocial support (education, counseling, support groups) rather than antidepressants.
Is there a short form of PAID?
Yes, the PAID-5 is a validated five-item abbreviated version published in 2007, yielding a 0–20 score (converted to 0–100). PAID-5 is ideal for busy clinics and frequent screening (monthly visits). Correlation with full PAID is high (r >0.90), but full PAID may be preferable at baseline assessment for completeness. PAID-5 can be used for follow-up monitoring of known distress.
How does PAID relate to glycemic control?
Elevated PAID correlates with higher HbA1c (r ≈ 0.25–0.40), meaning higher emotional burden is associated with worse glucose control. However, the relationship is not deterministic: some high-PAID patients achieve good control through excellent adherence coping mechanisms, while some low-PAID patients have poor control due to non-adherence or inadequate therapy. PAID is a clinical indicator of distress and risk but does not determine outcomes alone.
Should I use PAID or PAID-5?
Use full PAID (20 items) for baseline comprehensive assessment and detailed problem identification. Use PAID-5 for frequent monitoring (every 1–3 months) in busy settings. Studies show PAID-5 is nearly equivalent to full PAID for screening and outcome measurement but requires less time. Choice depends on clinical workflow: comprehensive assessment vs. efficient tracking.
Sources
- Welch, G. W., Weinger, K., Anderson, B., & Polonsky, W. H. (1997). Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire. Diabetes Care, 20(5), 696–702. link ↗
- Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Welch, G. W., Jacobson, A. M., Aponte, J. E., & Schwartz, C. E. (1995). Assessment of diabetes-related emotional and behavioral problems: Validation of the Problem Areas In Diabetes Scale. Diabetes Care, 18(10), 1330–1336. DOI: 10.1037/t49574-000 ↗
How to cite this page
ScholarGate. (2026, June 3). Problem Areas in Diabetes Scale (PAID). ScholarGate. https://scholargate.app/en/cardiology/problem-areas-in-diabetes
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Diabetes Distress ScaleCardiology↔ compare
- Diabetes Self-Efficacy ScaleCardiology↔ compare
- Hypoglycemia Fear SurveyCardiology↔ compare